ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells

A new research paper was published in Oncotarget’s Volume 15 on March 14, 2024, entitled, “ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.”

Kroger inks $1.4B settlement deal for opioid lawsuits

Grocery giant Kroger has inked a $1.4 billion deal to settle claims that its pharmacies exacerbated the opioid crisis. The company announced Friday that it

September 9, 2023

Medicare to cover more brain scans for Alzheimer’s patients

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will

July 17, 2023

Updated: As sales continue to slide, Catalent reaches deal with activist to add board seats and conduct review

As it deals with major declines in revenue, the replacement of top managers and issues with its manufacturing facilities, Catalent said it has reached an

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.